This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edwards, K. J.
Right arrow Articles by Campagnari, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, K. J.
Right arrow Articles by Campagnari, A. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, December 2005, p. 6139-6143, Vol. 43, No. 12
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.12.6139-6143.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Multiplex PCR Assay That Identifies the Major Lipooligosaccharide Serotype Expressed by Moraxella catarrhalis Clinical Isolates

Katie J. Edwards,1,2 Johanna M. Schwingel,1,2 Anup K. Datta,4 and Anthony A. Campagnari1,2,3*

Department of Microbiology and Immunology,1 Witebsky Center for Microbial Pathogenesis and Immunology,2 Department of Medicine, State University of New York at Buffalo, Buffalo, New York 14214,3 Glycobiology Research and Training Center, Department of Molecular and Cellular Medicine, University of California, San Diego, La Jolla, California 92093-06874

Received 20 September 2005/ Accepted 27 September 2005


arrow
ABSTRACT
 
A heterologous cluster of glycosyltransferase genes was identified in the three Moraxella catarrhalis LOS serotype strains. Multiple PCR primers designed to this region amplified products that differentiate between the serotypes more rapidly and efficiently than previously described serological analyses. This assay will be valuable for clinical and research-based studies.


arrow
TEXT
 
Moraxella catarrhalis, a gram-negative diplococcus, is considered a significant cause of acute otitis media in children and lower respiratory infections in adults with chronic obstructive pulmonary disease (COPD) (12, 21, 29). A number of putative virulence factors have been described for M. catarrhalis (8, 11, 12, 17, 20), including a surface-exposed lipooligosaccharide (LOS) (6, 18, 23, 32). Structural and serological studies with M. catarrhalis have described only three different LOS serotypes (termed A, B, and C), which vary in length and content of the oligosaccharide branches (3-5, 13, 15, 28). One serological study by Vaneechoutte et al. grouped clinical isolates into serotypes A (60%), B (30%), and C (5%), with 5% of the strains unidentified (28). That has been the only study to investigate the prevalence of specific M. catarrhalis LOS serotypes in the population. The difficulties with serological determinations of M. catarrhalis LOS expression are the limited quantities of antibodies, the absolute requirement for purified sample, and the potential for cross-reactivity between serotypes A and C (13, 24, 25).

Recently, a cluster of three glycosyltransferase (lgt) genes were identified and characterized in a strain of M. catarrhalis 7169 expressing serotype B LOS (6). Primers 406 and 408 (Table 1) designed to this region were subsequently used in PCRs with chromosomal DNA from M. catarrhalis 25238, the previously defined LOS serotype A strain, and M. catarrhalis RS10, the previously defined LOS serotype C strain (Table 2) (3, 4). PCR was performed in 50-µl reaction mixtures containing PCR SuperMix (Invitrogen, Carlsbad, CA), 20 pmol/µl of each primer, and 1 µl chromosomal DNA prepared as previously described (26). Amplifications were performed in a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, CA) according to the manufacturer's protocol for 25 cycles with an annealing temperature of 53.1°C and extension time of 4 min. Primers 406 and 408 (Table 1) produced an amplicon of 4.3 kb in serotype A and C strains, which was 1 kb larger than the product amplified in the serotype B strain, 7169 (data not shown).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Nucleotide sequence of oligonucleotide primers used for PCR-based LOS typing and sequencing in this study


View this table:
[in this window]
[in a new window]
  		TABLE 2. M. catarrhalis strains used in this study

Sequence analyses (MacVector 7.2 software; Accelrys, San Diego, CA) of the entire region amplified by primer 406 and flanking primer 704 (Table 1) identified an additional open reading frame upstream of the original lgt cluster described in 7169 and in the same orientation as lgt1, as illustrated in Fig. 1A and C. A ClustalW alignment with the translated sequence of this open reading frame (Lgt4) in both strains revealed 46% identity and 60% similarity to Lgt1, an {alpha}(1-2) glucosyltransferase in M. catarrhalis 7169 (6). The 5' end of this cluster in serotype A and C strains contained DNA sequence that is homologous to the 5' region of the lgt cluster in 7169, as depicted in all three clusters in Fig. 1A to C. Additional sequence analysis of the cluster in serotype A-expressing strains revealed a region of sequence divergence located at the 3' end of lgt2A, depicted in Fig. 1A. A ClustalW alignment with the translated sequence of Lgt2A revealed 61% identity and 75% similarity to Lgt2B/C (formally Lgt2), a ß(1-4) galactosyltransferase in M. catarrhalis 7169 (6). A ClustalW alignment with the translated sequences of Lgt1 and Lgt3 from both serotypes A and C revealed ≥98% identity to the respective homologous Lgt enzymes identified in M. catarrhalis 7169 (6). These observations were confirmed by sequencing the entire lgt cluster in a second serotype C strain, CCUG 26391, and another serotype A strain, 27335 (Table 2) (data not shown).



View larger version (11K):
[in this window]
[in a new window]
  		FIG. 1. Organization of lgt clusters in strains of M. catarrhalis expressing different LOS serotypes and binding sites of the primers used in the multiplex PCRs. (A) Representative (putative) lgt cluster in a LOS serotype A genome from M. catarrhalis strain ATCC 25238 (NCBI accession number DQ137417). (B) Representative lgt cluster in a LOS serotype B genome from M. catarrhalis strain 7169 (Edwards, 2005). (C) Representative (putative) lgt cluster in a LOS serotype C genome from M. catarrhalis strain RS10 (NCBI accession number DQ137418). The 5' end of the cluster in serotype A and C strains contained DNA sequence that is homologous to the 5' region of the lgt cluster in 7169, as depicted by gray shading in all three clusters (A to C). Black sequence portion in panel A represents a region of sequence divergence at the 3' end of lgt2A.

Due to the homologous DNA sequence 5' of the lgt cluster in all three serotype strains, we implemented a strategy of multiplex PCR in which primers 406 and 649 were the forward primers for serotype B/C strains and serotype A strains, respectively, and primer 408 was the reverse primer for all three serotypes, as depicted in Fig. 1. This single PCR produces amplicons of 1.9 kb, 3.3 kb, and 4.3 kb for serotypes A, B, and C, respectively. Figure 2 (lanes 1 to 3) is a representative agarose gel depicting the amplicons resulting from this multiplex PCR using chromosomal DNA from M. catarrhalis LOS serotypes A, B, and C, the control strains ATCC 25238, 7169, and RS10, respectively (Table 2) (3, 4, 6). Other M. catarrhalis clinical isolates (Table 2) were also tested, some representing a geographically diverse panel (Fig. 2, lanes 14 to 18), as well as isolates from a local population of adults with COPD (Fig. 2, lanes 4 to 8) and children with otitis media with effusion (OME) (Fig. 2, lanes 9 to 13). Overall, 152 M. catarrhalis strains were typed using this system, and the results of these reactions are summarized in Table 3. The percentage of strains expressing serotype A, B, or C LOS was 64%, 30%, and 6%, respectively, which is consistent with the previous data (13, 28). However, the percentage of M. catarrhalis isolates expressing serotype A LOS was relatively high for the COPD isolates (81%) and relatively low for the diverse global isolates (46%). At this time it is difficult to determine the significance of this observation, and further analyses are needed to determine whether LOS serotype is a factor for tissue tropism (i.e., inner ear or lung), colonization, or subsequent infection.



View larger version (24K):
[in this window]
[in a new window]
  		FIG. 2. Representative multiplex PCR test using primers 406, 408, and 649 (Table 1) with chromosomal DNA isolated from various M. catarrhalis isolates. Lanes 1 to 3 show amplicons from the three LOS serotype control strains: LOS serotype A, ATCC 25238 (lane 1); LOS serotype B, 7169 (lane 2); and LOS serotype C, RS10 (lane 3). Lanes 4 to 8 contain amplicons from five COPD patients' isolates: 3P3B1 (lane 4), 51P9B1 (lane 5), 5P26B1 (lane 6), 18P6B1 (lane 7), and 12P80B1 (lane 8). Lanes 9 to 13 contain amplicons from five children's OME isolates: HF-039 (lane 9), HF-2246 (lane 10), HF-165 (lane 11), HF-218 (lane 12), and HF-006 (lane 13). Lanes 14 to 18 contain amplicons from five geographically diverse (global) isolates: 2951 (lane 14), 035E (lane 15), CCUG 3292 (lane 16), ATCC 43617 (lane 17), and CCUG 26391 (lane 18).


View this table:
[in this window]
[in a new window]
  		TABLE 3. LOS serotypes expressed by M. catarrhalis strains isolated from different populations of patients as determined by multiplex PCR

In order to confirm that the multiplex PCR method specifically correlated with the LOS serotype expressed by clinical isolates, compositional analysis and mass spectroscopy were performed as described previously (16). LOS was purified from a selected group of M. catarrhalis clinical isolates representing the three major serotypes, and oligosaccharides were isolated as described previously (6, 31). A portion (100 µg) of each OS was methanolyzed, trimethylsilylated, and analyzed by gas chromatography-mass spectrometry (MS). The glycosyl composition analyses for the OSs from M. catarrhalis strains 3P3B1 and 12P80B1 detected galactose, glucose, 3-deoxy-D-manno-octulosonic acid (KDO), and 2-acetamido-2-deoxy glucose as the major monosaccharide constituents, whereas the M. catarrhalis strain 43617 OS contained galactose, glucose, and KDO as the major monosaccharide constituents, with the absence of 2-acetamido-2-deoxy glucose residues (Table 4).


View this table:
[in this window]
[in a new window]
  		TABLE 4. Ions observed from MALDI-TOF MS analyses of OSs from LOS isolated from different strains of M. catarrhalis and their proposed composition

Methylation analysis of the strain 3P3B1 OS revealed the presence of terminal galactopyranose, terminal glucopyranose, 2-linked glucopyranose, 4-linked glucopyranose, 4-linked galactopyranose, 2,3,6-linked glucopyranose, and terminal 2-acetamido-2-deoxy glucopyranoside, indicating that 3P3B1 expresses serotype A LOS. Analysis of the strain 12P80B1 OS revealed the same profile as 3P3B1, except this sample contained 4-linked 2-acetamido-2-deoxy glucopyranoside rather than terminal 2-acetamido-2-deoxy glucopyranoside, indicating that 12P80B1 expresses serotype C LOS. Analysis of the strain 43617 OS revealed the presence of terminal galactopyranose, terminal glucopyranose, 2-linked glucopyranose, 4-linked glucopyranose, 4-linked galactopyranose, and 2,3,6-linked glucopyranose, with the absence of the 2-acetamido-2-deoxy glucopyranoside residues, indicating that 43617 expresses serotype B LOS. Analyses of the molecular masses of the OSs by negative-ion matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) MS, using dihydroxybenzoic acid as the matrix, as previously described (16), were heterogeneous and consistent with the composition and linkage analyses (data not shown). The results of the mass spectrometric analysis of the OSs are summarized in Table 4. These structural analyses were also performed with M. catarrhalis clinical isolates 035E (serotype A), 5P26B1 (serotype B), and CCUG 26391 (serotype C) (strains referenced in Table 1) and were consistent with the above analyses (data not shown).

The species specificity of the multiplex PCR assay was also evaluated with chromosomal DNA isolated from 20 strains representing 16 different species, within the genus Moraxella, as well as other mucosal pathogens and commensal organisms (Table 2). The LOS serotype-specific primers did not amplify products from any of the 20 heterologous strains tested in this study (data not shown).

In conclusion, the results in this study indicate that this multiplex PCR test is a specific and highly effective assay for the identification of LOS serotypes expressed by M. catarrhalis strains. In addition, this system may have the added advantage of identifying a clinical isolate as an M. catarrhalis strain, although more data are needed. A single-step PCR method may prove to be a useful tool for basic research studies designed to determine the role of LOS in relation to colonization and pathogenesis, as well as provide a more specific means for clinical investigation of the type of M. catarrhalis strains infecting specific patients.


arrow
ACKNOWLEDGMENTS
 
This research was supported by Public Health Service research grants AI46422 and DC005837 (A.A.C.). K.J.E. is also supported as a graduate student fellow by NIH training grant AI07614.

We thank Timothy Murphy for supplying the M. catarrhalis clinical isolates from the COPD clinic at the VA Medical Center in Buffalo, N.Y. We also thank Howard Faden for supplying the children's M. catarrhalis isolates from the Women and Children's Hospital in Buffalo, N.Y.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Microbiology, University at Buffalo, Biomedical Research Bldg. Rm. 143, 3435 Main St., Buffalo, NY 14214. Phone: (716) 829-2673. Fax: (716) 829-3889. E-mail: aac{at}buffalo.edu. Back


arrow
REFERENCES
 
    1
  1. Bakri, F., A. L. Brauer, S. Sethi, and T. F. Murphy. 2002. Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. J. Infect. Dis. 185:632-640.[CrossRef][Medline]
    2. 2
  2. Campagnari, A. A., R. Karalus, M. Apicella, W. Melaugh, A. J. Lesse, and B. W. Gibson. 1994. Use of pyocin to select a Haemophilus ducreyi variant defective in lipooligosaccharide biosynthesis. Infect. Immun. 62:2379-2386.[Abstract/Free Full Text]
    3. 3
  3. Edebrink, P., P. E. Jansson, M. M. Rahman, G. Widmalm, T. Holme, and M. Rahman. 1995. Structural studies of the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C. Carbohydr. Res. 266:237-261.[CrossRef][Medline]
    4. 4
  4. Edebrink, P., P. E. Jansson, M. M. Rahman, G. Widmalm, T. Holme, and M. Rahman. 1994. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr. Res. 257:269-284.[CrossRef][Medline]
    5. 5
  5. Edebrink, P., P. E. Jansson, G. Widmalm, T. Holme, and M. Rahman. 1996. The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292. Carbohydr. Res. 295:127-146.[Medline]
    6. 6
  6. Edwards, K. J., S. Allen, B. W. Gibson, and A. A. Campagnari. 2005. Characterization of a cluster of three glycosyltransferase enzymes essential for Moraxella catarrhalis lipooligosaccharide assembly. J. Bacteriol. 187:2939-2947.[Abstract/Free Full Text]
    7. 7
  7. Faden, H., J. Hong, and T. Murphy. 1992. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect. Immun. 60:3824-3829.[Abstract/Free Full Text]
    8. 8
  8. Forsgren, A., M. Brant, M. Karamehmedovic, and K. Riesbeck. 2003. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect. Immun. 71:3302-3309.[Abstract/Free Full Text]
    9. 9
  9. Furano, K., and A. A. Campagnari. 2003. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infect. Immun. 71:1843-1848.[Abstract/Free Full Text]
    10. 10
  10. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. Paris, G. H. McCracken, Jr., and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872.[Medline]
    11. 11
  11. Holm, M. M., S. L. Vanlerberg, I. M. Foley, D. D. Sledjeski, and E. R. Lafontaine. 2004. The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect. Immun. 72:1906-1913.[Abstract/Free Full Text]
    12. 12
  12. Holm, M. M., S. L. Vanlerberg, D. D. Sledjeski, and E. R. Lafontaine. 2003. The Hag protein of Moraxella catarrhalis strain O35E is associated with adherence to human lung and middle ear cells. Infect. Immun. 71:4977-4984.[Abstract/Free Full Text]
    13. 13
  13. Holme, T., M. Rahman, P. E. Jansson, and G. Widmalm. 1999. The lipopolysaccharide of Moraxella catarrhalis structural relationships and antigenic properties. Eur. J. Biochem. 265:524-529.[Medline]
    14. 14
  14. Hu, W. G., J. Chen, J. C. McMichael, and X. X. Gu. 2001. Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis. Infect. Immun. 69:1358-1363.[Abstract/Free Full Text]
    15. 15
  15. Jèonsson, I., T. Holme, A. Krook, M. Rahman, and M. Thoraen. 1992. Variability of surface-exposed antigens of different strains of Moraxella catarrhalis. Eur. J. Clin. Microbiol. Infect. Dis. 11:919-922.[CrossRef][Medline]
    16. 16
  16. Kahler, C. M., A. Datta, Y. L. Tzeng, R. W. Carlson, and D. S. Stephens. 2005. Inner core assembly and structure of the lipooligosaccharide of Neisseria meningitidis: capacity of strain NMB to express all known immunotype epitopes. Glycobiology 15:409-419.[Abstract/Free Full Text]
    17. 17
  17. Lafontaine, E. R., L. D. Cope, C. Aebi, J. L. Latimer, G. H. McCracken, Jr., and E. J. Hansen. 2000. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J. Bacteriol. 182:1364-1373.[Abstract/Free Full Text]
    18. 18
  18. Luke, N. R., S. Allen, B. W. Gibson, and A. A. Campagnari. 2003. Identification of a 3-deoxy-D-manno-octulosonic acid biosynthetic operon in Moraxella catarrhalis and analysis of a KdsA-deficient isogenic mutant. Infect. Immun. 71:6426-6434.[Abstract/Free Full Text]
    19. 19
  19. Luke, N. R., and A. A. Campagnari. 1999. Construction and characterization of Moraxella catarrhalis mutants defective in expression of transferrin receptors. Infect. Immun. 67:5815-5819.[Abstract/Free Full Text]
    20. 20
  20. Luke, N. R., A. J. Howlett, J. Shao, and A. A. Campagnari. 2004. Expression of type IV pili by Moraxella catarrhalis is essential for natural competence and is affected by iron limitation. Infect. Immun. 72:6262-6270.[Abstract/Free Full Text]
    21. 21
  21. Murphy, T. F., A. L. Brauer, B. J. Grant, and S. Sethi. 2005. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am. J. Respir. Crit. Care Med. 172:195-199.[Abstract/Free Full Text]
    22. 22
  22. Murphy, T. F., C. Kirkham, E. DeNardin, and S. Sethi. 1999. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Infect. Immun. 67:4578-4585.[Abstract/Free Full Text]
    23. 23
  23. Peng, D., B. P. Choudhury, R. S. Petralia, R. W. Carlson, and X. X. Gu. 2005. Roles of 3-deoxy-D-manno-2-octulosonic acid transferase from Moraxella catarrhalis in lipooligosaccharide biosynthesis and virulence. Infect. Immun. 73:4222-4230.[Abstract/Free Full Text]
    24. 24
  24. Rahman, M., and T. Holme. 1996. Antibody response in rabbits to serotype-specific determinants in lipopolysaccharides from Moraxella catarrhalis. J. Med. Microbiol. 44:348-354.[Abstract/Free Full Text]
    25. 25
  25. Rahman, M., A. B. Jonsson, and T. Holme. 1998. Monoclonal antibodies to the epitope {alpha}-Gal-(1-4)-ß-Gal-(1- of Moraxella catarrhalis) LPS react with a similar epitope in type IV pili of Neisseria meningitidis. Microb. Pathog. 24:299-308.[CrossRef][Medline]
    26. 26
  26. Russo, T. A., J. E. Guenther, S. Wenderoth, and M. M. Frank. 1993. Generation of isogenic K54 capsule-deficient Escherichia coli strains through TnphoA-mediated gene disruption. Mol. Microbiol. 9:357-364.[CrossRef][Medline]
    27. 27
  27. Russo, T. A., J. S. Thompson, V. G. Godoy, and M. H. Malamy. 1990. Cloning and expression of the Bacteroides fragilis TAL2480 neuraminidase gene, nanH, in Escherichia coli. J. Bacteriol. 172:2594-2600.[Abstract/Free Full Text]
    28. 28
  28. Vaneechoutte, M., G. Verschraegen, G. Claeys, and A. M. Van Den Abeele. 1990. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J. Clin. Microbiol. 28:182-187.[Abstract/Free Full Text]
    29. 29
  29. Verduin, C. M., C. Hol, A. Fleer, H. van Dijk, and A. van Belkum. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 15:125-144.[Abstract/Free Full Text]
    30. 30
  30. Wallace, R. J., Jr., V. A. Steingrube, D. R. Nash, D. G. Hollis, C. Flanagan, B. A. Brown, A. Labidi, and R. E. Weaver. 1989. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata. Antimicrob. Agents Chemother. 33:1845-1854.[Abstract/Free Full Text]
    31. 31
  31. York, W. S., A. G. Darville, M. McNeil, T. T. Stevenson, and P. Albersheim. 1985. Isolation and characterization of plant cell walls and cell wall components. Methods Enzymol. 118:3-40.
    32. 32
  32. Zaleski, A., N. K. Scheffler, P. Densen, F. K. Lee, A. A. Campagnari, B. W. Gibson, and M. A. Apicella. 2000. Lipooligosaccharide Pk (Gal{alpha}1-4Galß1-4Glc) epitope of Moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum. Infect. Immun. 68:5261-5268.[Abstract/Free Full Text]

Journal of Clinical Microbiology, December 2005, p. 6139-6143, Vol. 43, No. 12
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.12.6139-6143.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Schwingel, J. M., Edwards, K. J., Cox, A. D., Masoud, H., Richards, J. C., St. Michael, F., Tekwe, C. D., Sethi, S., Murphy, T. F., Campagnari, A. A. (2009). Use of Moraxella catarrhalis Lipooligosaccharide Mutants To Identify Specific Oligosaccharide Epitopes Recognized by Human Serum Antibodies. Infect. Immun. 77: 4548-4558 [Abstract] [Full Text]  
  • Schwingel, J. M, Michael, F. S., Cox, A. D, Masoud, H., Richards, J. C, Campagnari, A. A (2008). A unique glycosyltransferase involved in the initial assembly of Moraxella catarrhalis lipooligosaccharides. Glycobiology 18: 447-455 [Abstract] [Full Text]  
  • Verhaegh, S. J. C., Streefland, A., Dewnarain, J. K., Farrell, D. J., van Belkum, A., Hays, J. P. (2008). Age-related genotypic and phenotypic differences in Moraxella catarrhalis isolates from children and adults presenting with respiratory disease in 2001-2002. Microbiology 154: 1178-1184 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Edwards, K. J.
Right arrow Articles by Campagnari, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, K. J.
Right arrow Articles by Campagnari, A. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»